Petefészekrák: vizsgálatok itt: Svédország
13 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Where
- Lund, Solna, Uppsala
- Életkor
- 18 év and over
- People
- 582 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06819007 · EU 2024-516982-35-00 - 3. fázisTaking peopleA Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Where
- Linkoping, Solna
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07318558 · EU 2023-508047-40-00 - 1/2. fázisTaking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Lund, Stockholm
- Életkor
- 18 év to 130 év
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - No phaseTaking peopleFrailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer
- Where
- Gothenburg, Linköping, Lund, Stockholm
- Életkor
- 18 év and over
- People
- 475
- Run by
- Sahar Salehi
See details and how to joinNCT06298877 - 1/2. fázisTaking peopleBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Where
- Gothenburg, Lund, Stockholm
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Lund, Solna
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 3. fázisTaking peopleAZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Where
- Linkoping, Lund, Solna, Umea, Uppsala
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00 - 2/3. fázisTaking peopleStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Where
- Solna
- Életkor
- 18 év and over
- People
- 175 worldwide
- Run by
- GE Healthcare
See details and how to joinNCT07219238 · EU 2024-519384-18-00 - 2. fázisTaking peopleTinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
- Where
- Eksjo, Goteborg, Jonkoping, Linkoping, Umea, Varnamo, Vastervik
- Életkor
- 18 év and over
- People
- 40
- Run by
- University Hospital, Linkoeping
See details and how to joinNCT05284552 · EU 2024-515450-24-00 - No phaseTaking peopleTUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- Where
- Stockholm
- Életkor
- 25 év to 50 év
- People
- 3000 worldwide
- Run by
- University Medical Center Nijmegen
See details and how to joinNCT04294927 - No phaseNot yet taking people in SvédországMenopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention
- Where
- Umeå
- Életkor
- 20 év to 65 év
- People
- 2100
- Run by
- Umeå University
See details and how to joinNCT07423143 - No phaseTaking peoplePrognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
- Where
- Umeå
- Életkor
- 18 év and over
- People
- 120
- Run by
- Region Västerbotten
See details and how to joinNCT05855941 - 1. fázisTaking peoplePET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
- Where
- Stockholm
- Életkor
- 19 év and over
- People
- 410
- Run by
- Karolinska University Hospital
See details and how to joinNCT05172310